HTG MOLECULAR DIAGNOSTICS, INC Annual Operating Income (Loss) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2022.
  • Htg Molecular Diagnostics, Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$5.01M, a 19.9% increase year-over-year.
  • Htg Molecular Diagnostics, Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$19.6M, a 0.47% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Operating Income (Loss) for 2022 was -$20.8M, a 16.9% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Operating Income (Loss) for 2021 was -$17.8M, a 9% increase from 2020.
  • Htg Molecular Diagnostics, Inc annual Operating Income (Loss) for 2020 was -$19.6M, a 3.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$20.8M -$3.01M -16.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$17.8M +$1.76M +9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$19.6M -$626K -3.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$19M -$2.8M -17.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$16.2M +$1.56M +8.82% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 -$17.7M +$6.61M +27.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$24.3M -$5.44M -28.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 -$18.9M -$6.04M -47% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
2014 -$12.8M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.